Búsqueda | Biblioteca Virtual en Salud

Morgentaler, Abraham; Zitzmann, Michael; Traish, Abdulmaged M; Fox, Anthony W; Jones, T Hugh; Maggi, Mario; Arver, Stefan; Aversa, Antonio; Chan, Juliana C N; Dobs, Adrian S; Hackett, Geoffrey I; Hellstrom, Wayne J; Lim, Peter; Lunenfeld, Bruno; Mskhalaya, George; Schulman, Claude C; Torres, Luiz O.

Mayo Clin Proc ; 91(7): 881-96, 2016 07.

Artículo en Inglés | MEDLINE | ID: mdl-27313122

16.

Migraine during pregnancy: options for therapy.

Fox, Anthony W; Diamond, Merle L; Spierings, Egilius L H.

CNS Drugs ; 19(6): 465-81, 2005.

Artículo en Inglés | MEDLINE | ID: mdl-15962998

17.

The Pharmaceutical Year That Was, 2020.

Fox, Anthony W.

Pharmaceut Med ; 34(6): 365-368, 2020 12.

Artículo en Inglés | MEDLINE | ID: mdl-33289911

18.

The Pharmaceutical Year That Was, 2019.

Fox, Anthony W.

Pharmaceut Med ; 33(6): 445-447, 2019 12.

Artículo en Inglés | MEDLINE | ID: mdl-31933244

19.

Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases.

Morimoto, Bruce H; Fox, Anthony W; Stewart, Alistair J; Gold, Michael.

Expert Rev Clin Pharmacol ; 6(5): 483-502, 2013 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-23971871

20.

Efficacy, end points and eventualities: sumatriptan/naproxen versus butalbital/paracetamol/caffeine in the treatment of migraine.

Fox, Anthony W.

Expert Rev Clin Pharmacol ; 5(5): 513-6, 2012 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-23121272

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Safety Pharmacology in Drug Discovery and Development.

Where is European Regulation 536/2014 Taking Us?

Oral sumatriptan and almotriptan--delimiting the MAOI effect.

Elder abuse.

Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.

How well do Regulation 28 reports serve future public health and safety?

Why Does the Precautionary Principle Suffice for Blood Regulation?

Subcutaneous sumatriptan pharmacokinetics: delimiting the monoamine oxidase inhibitor effect.

Rapid oral transmucosal absorption of sumatriptan, and pharmacodynamics in acute migraine.

Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of use.

Disease modification in migraine: study design and sample size implications.

The Pharmaceutical Year That Was, 2023.

Differential research impact in cancer practice guidelines' evidence base: lessons from ESMO, NICE and SIGN.

The Pharmaceutical Year that was, 2021.

Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions.

Migraine during pregnancy: options for therapy.

The Pharmaceutical Year That Was, 2020.

The Pharmaceutical Year That Was, 2019.

Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseases.

Efficacy, end points and eventualities: sumatriptan/naproxen versus butalbital/paracetamol/caffeine in the treatment of migraine.